Cargando…
The Mechanism of Ajmaline and Thus Brugada Syndrome: Not Only the Sodium Channel!
Ajmaline is an anti-arrhythmic drug that is used to unmask the type-1 Brugada syndrome (BrS) electrocardiogram pattern to diagnose the syndrome. Thus, the disease is defined at its core as a particular response to this or other drugs. Ajmaline is usually described as a sodium-channel blocker, and mo...
Autores principales: | Monasky, Michelle M., Micaglio, Emanuele, D'Imperio, Sara, Pappone, Carlo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733296/ https://www.ncbi.nlm.nih.gov/pubmed/35004896 http://dx.doi.org/10.3389/fcvm.2021.782596 |
Ejemplares similares
-
Brugada Syndrome: Warning of a Systemic Condition?
por: D'Imperio, Sara, et al.
Publicado: (2021) -
Early Morning QT Prolongation During Hypoglycemia: Only a Matter of Glucose?
por: D'Imperio, Sara, et al.
Publicado: (2021) -
Evaluating the Use of Genetics in Brugada Syndrome Risk Stratification
por: Monasky, Michelle M., et al.
Publicado: (2021) -
Impact of Dietary Factors on Brugada Syndrome and Long QT Syndrome
por: D’Imperio, Sara, et al.
Publicado: (2021) -
Further Considerations in Childhood-Onset Hypertrophic Cardiomyopathy Genetic Testing
por: Monasky, Michelle M., et al.
Publicado: (2021)